Inhibitors of Ras-SOS Interactions
- PMID: 26630662
- DOI: 10.1002/cmdc.201500481
Inhibitors of Ras-SOS Interactions
Abstract
Activating Ras mutations are found in about 30 % of human cancers. Ras activation is regulated by guanine nucleotide exchange factors, such as the son of sevenless (SOS), which form protein-protein interactions (PPIs) with Ras and catalyze the exchange of GDP by GTP. This is the rate-limiting step in Ras activation. However, Ras surfaces lack any evident suitable pockets where a molecule might bind tightly, rendering Ras proteins still 'undruggable' for over 30 years. Among the alternative approaches is the design of inhibitors that target the Ras-SOS PPI interface, a strategy that is gaining increasing recognition for treating Ras mutant cancers. Herein we focus on data that has accumulated over the past few years pertaining to the design of small-molecule modulators or peptide mimetics aimed at the interface of the Ras-SOS PPI. We emphasize, however, that even if such Ras-SOS therapeutics are potent, drug resistance may emerge. To counteract this development, we propose "pathway drug cocktails", that is, drug combinations aimed at parallel (or compensatory) pathways. A repertoire of classified cancer, cell/tissue, and pathway/protein combinations would be beneficial toward this goal.
Keywords: H-Ras; K-Ras; KRAS; oncogenic mutations; peptide mimetics; protein-protein interactions.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
An orthosteric inhibitor of the RAS-SOS interaction.Enzymes. 2013;34 Pt. B:25-39. doi: 10.1016/B978-0-12-420146-0.00002-0. Epub 2013 Nov 7. Enzymes. 2013. PMID: 25034099 Review.
-
Structural analysis of autoinhibition in the Ras activator Son of sevenless.Cell. 2004 Oct 29;119(3):393-405. doi: 10.1016/j.cell.2004.10.005. Cell. 2004. PMID: 15507210
-
The structural basis of the activation of Ras by Sos.Nature. 1998 Jul 23;394(6691):337-43. doi: 10.1038/28548. Nature. 1998. PMID: 9690470
-
Loop domain peptides from the SOS ras-guanine nucleotide exchange protein, identified from molecular dynamics calculations, strongly inhibit ras signaling.Protein J. 2004 Apr;23(3):229-34. doi: 10.1023/b:jopc.0000026418.82786.5e. Protein J. 2004. PMID: 15200054
-
The Interdependent Activation of Son-of-Sevenless and Ras.Cold Spring Harb Perspect Med. 2019 Feb 1;9(2):a031534. doi: 10.1101/cshperspect.a031534. Cold Spring Harb Perspect Med. 2019. PMID: 29610148 Free PMC article. Review.
Cited by
-
Personal Mutanomes Meet Modern Oncology Drug Discovery and Precision Health.Pharmacol Rev. 2019 Jan;71(1):1-19. doi: 10.1124/pr.118.016253. Epub 2018 Dec 13. Pharmacol Rev. 2019. PMID: 30545954 Free PMC article. Review.
-
Mechanism of activation and the rewired network: New drug design concepts.Med Res Rev. 2022 Mar;42(2):770-799. doi: 10.1002/med.21863. Epub 2021 Oct 25. Med Res Rev. 2022. PMID: 34693559 Free PMC article. Review.
-
Computational Insights into the Interactions between Calmodulin and the c/nSH2 Domains of p85α Regulatory Subunit of PI3Kα: Implication for PI3Kα Activation by Calmodulin.Int J Mol Sci. 2018 Jan 4;19(1):151. doi: 10.3390/ijms19010151. Int J Mol Sci. 2018. PMID: 29300353 Free PMC article.
-
Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers.PLoS Comput Biol. 2019 Mar 28;15(3):e1006658. doi: 10.1371/journal.pcbi.1006658. eCollection 2019 Mar. PLoS Comput Biol. 2019. PMID: 30921324 Free PMC article. Review.
-
Mechanistic insights into the effect of phosphorylation on Ras conformational dynamics and its interactions with cell signaling proteins.Comput Struct Biotechnol J. 2021 Feb 9;19:1184-1199. doi: 10.1016/j.csbj.2021.01.044. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 33680360 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
